Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The Regulation of Iron Absorption and Homeostasis.

Wallace DF.

Clin Biochem Rev. 2016 May;37(2):51-62. Review.

2.

Regulation of the Iron Homeostatic Hormone Hepcidin.

Sangkhae V, Nemeth E.

Adv Nutr. 2017 Jan 17;8(1):126-136. doi: 10.3945/an.116.013961. Print 2017 Jan. Review.

PMID:
28096133
3.

Transforming Growth Factor β1 (TGF-β1) Activates Hepcidin mRNA Expression in Hepatocytes.

Chen S, Feng T, Vujić Spasić M, Altamura S, Breitkopf-Heinlein K, Altenöder J, Weiss TS, Dooley S, Muckenthaler MU.

J Biol Chem. 2016 Jun 17;291(25):13160-74. doi: 10.1074/jbc.M115.691543. Epub 2016 Apr 27.

PMID:
27129231
4.

Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the Liver.

Zhao N, Maxson JE, Zhang RH, Wahedi M, Enns CA, Zhang AS.

J Biol Chem. 2016 Jun 3;291(23):12322-35. doi: 10.1074/jbc.M116.721191. Epub 2016 Apr 12.

PMID:
27072365
5.

New strategies to target iron metabolism for the treatment of beta thalassemia.

Oikonomidou PR, Casu C, Rivella S.

Ann N Y Acad Sci. 2016 Mar;1368(1):162-8. doi: 10.1111/nyas.13018. Epub 2016 Feb 25.

6.

The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension.

Ormiston ML, Upton PD, Li W, Morrell NW.

Glob Cardiol Sci Pract. 2015 Nov 17;2015(4):47. doi: 10.5339/gcsp.2015.47. eCollection 2015 Nov 17.

7.

Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stage.

Chen Q, Wang L, Ma Y, Wu X, Jin L, Yu F.

Thorac Cancer. 2014 Jan;5(1):14-24. doi: 10.1111/1759-7714.12046. Epub 2014 Jan 2.

8.

Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.

Canali S, Core AB, Zumbrennen-Bullough KB, Merkulova M, Wang CY, Schneyer AL, Pietrangelo A, Babitt JL.

Endocrinology. 2016 Mar;157(3):1146-62. doi: 10.1210/en.2015-1747. Epub 2016 Jan 6.

9.

Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Blanchette NL, Manz DH, Torti FM, Torti SV.

Expert Rev Hematol. 2016;9(2):169-86. doi: 10.1586/17474086.2016.1124757. Epub 2015 Dec 15. Review.

10.

Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation.

Chen H, Choesang T, Li H, Sun S, Pham P, Bao W, Feola M, Westerman M, Li G, Follenzi A, Blanc L, Rivella S, Fleming RE, Ginzburg YZ.

Haematologica. 2016 Mar;101(3):297-308. doi: 10.3324/haematol.2015.127902. Epub 2015 Dec 3.

11.

Effects of developmental iron deficiency and post-weaning iron repletion on the levels of iron transporter proteins in rats.

Oh S, Shin PK, Chung J.

Nutr Res Pract. 2015 Dec;9(6):613-8. doi: 10.4162/nrp.2015.9.6.613. Epub 2015 Oct 26.

12.

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.

Lyberopoulou A, Chachami G, Gatselis NK, Kyratzopoulou E, Saitis A, Gabeta S, Eliades P, Paraskeva E, Zachou K, Koukoulis GK, Mamalaki A, Dalekos GN, Simos G.

PLoS One. 2015 Aug 13;10(8):e0135486. doi: 10.1371/journal.pone.0135486. eCollection 2015 Aug 13.

13.

Regulation of Iron Metabolism by Hepcidin under Conditions of Inflammation.

Schmidt PJ.

J Biol Chem. 2015 Jul 31;290(31):18975-83. doi: 10.1074/jbc.R115.650150. Epub 2015 Jun 8. Review.

14.

Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth.

Shi Y, Chen GB, Huang XX, Xiao CX, Wang HH, Li YS, Zhang JF, Li S, Xia Y, Ren JL, Guleng B.

Oncotarget. 2015 Aug 21;6(24):20540-54.

15.

Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein.

Healey EG, Bishop B, Elegheert J, Bell CH, Padilla-Parra S, Siebold C.

Nat Struct Mol Biol. 2015 Jun;22(6):458-65. doi: 10.1038/nsmb.3016. Epub 2015 May 4.

16.

Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?

Rausa M, Pagani A, Nai A, Campanella A, Gilberti ME, Apostoli P, Camaschella C, Silvestri L.

PLoS One. 2015 Apr 10;10(4):e0122696. doi: 10.1371/journal.pone.0122696. eCollection 2015 Apr 10.

17.

Identification of TMPRSS6 cleavage sites of hemojuvelin.

Rausa M, Ghitti M, Pagani A, Nai A, Campanella A, Musco G, Camaschella C, Silvestri L.

J Cell Mol Med. 2015 Apr;19(4):879-88. doi: 10.1111/jcmm.12462. Epub 2015 Feb 22.

18.

Potential roles of BMP9 in liver fibrosis.

Bi J, Ge S.

Int J Mol Sci. 2014 Nov 11;15(11):20656-67. doi: 10.3390/ijms151120656. Review.

19.

Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration.

Tsugawa D, Oya Y, Masuzaki R, Ray K, Engers DW, Dib M, Do N, Kuramitsu K, Ho K, Frist A, Yu PB, Bloch KD, Lindsley CW, Hopkins CR, Hong CC, Karp SJ.

J Pharmacol Exp Ther. 2014 Dec;351(3):549-58. doi: 10.1124/jpet.114.216903. Epub 2014 Sep 30.

20.

Supplemental Content

Support Center